Hideo Nambu

447 total citations
13 papers, 275 citations indexed

About

Hideo Nambu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Complementary and alternative medicine. According to data from OpenAlex, Hideo Nambu has authored 13 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 4 papers in Complementary and alternative medicine. Recurrent topics in Hideo Nambu's work include Cardiovascular and exercise physiology (4 papers), Mitochondrial Function and Pathology (3 papers) and Heart Failure Treatment and Management (3 papers). Hideo Nambu is often cited by papers focused on Cardiovascular and exercise physiology (4 papers), Mitochondrial Function and Pathology (3 papers) and Heart Failure Treatment and Management (3 papers). Hideo Nambu collaborates with scholars based in Japan and Denmark. Hideo Nambu's co-authors include Shingo Takada, Shintaro Kinugawa, Takaaki Furihata, Naoya Kakutani, Takashi Yokota, Arata Fukushima, Satoshi Maekawa, Junichi Matsumoto, Hisataka Sabe and Toshihisa Anzai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and European Journal of Pharmacology.

In The Last Decade

Hideo Nambu

11 papers receiving 274 citations

Peers

Countries citing papers authored by Hideo Nambu

Since Specialization

Citations

This map shows the geographic impact of Hideo Nambu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideo Nambu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideo Nambu more than expected).

Fields of papers citing papers by Hideo Nambu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideo Nambu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideo Nambu. The network helps show where Hideo Nambu may publish in the future.

Co-authorship network of co-authors of Hideo Nambu

This figure shows the co-authorship network connecting the top 25 collaborators of Hideo Nambu. A scholar is included among the top collaborators of Hideo Nambu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideo Nambu. Hideo Nambu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Succinyl-CoA-based energy metabolism dysfunction in chronic heart failure 2022 ·Proceedings of the National Academy of Sciences ·Shingo Takada, Satoshi Maekawa, Takaaki Furihata, Naoya Kakutani, Daiki Setoyama, Koji Ueda, Hideo Nambu, (unknown), Haruka Handa, (unknown), (unknown), (unknown), Arata Fukushima, Takashi Yokota, Dongchon Kang, Shintaro Kinugawa, Hisataka Sabe	37
2	Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice 2021 ·BMC Pharmacology and Toxicology ·Takaaki Furihata, Satoshi Maekawa, Shingo Takada, Naoya Kakutani, Hideo Nambu, (unknown), Takashi Yokota, Shintaro Kinugawa	5
3	Angiotensin‐converting enzyme inhibitor prevents skeletal muscle fibrosis in diabetic mice 2021 ·Experimental Physiology ·Naoya Kakutani, Shingo Takada, Hideo Nambu, Satoshi Maekawa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takaaki Furihata, Arata Fukushima, Takashi Yokota, Shintaro Kinugawa	7
4	Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction mice 2020 ·Skeletal Muscle ·Naoya Kakutani, Shingo Takada, Hideo Nambu, Junichi Matsumoto, Takaaki Furihata, Takashi Yokota, Arata Fukushima, Shintaro Kinugawa	8
5	Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction 2020 ·Cardiovascular Diabetology ·Takahiro Abe, Takashi Yokota, Arata Fukushima, Naoya Kakutani, Takashi Katayama, (unknown), Satoshi Maekawa, Hideo Nambu, (unknown), (unknown), (unknown), Shingo Takada, Isao Yokota, Koichi Okita, Shintaro Kinugawa, Toshihisa Anzai	10
6	Brain-Derived Neurotrophic Factor Improves Impaired Fatty Acid Oxidation Via the Activation of Adenosine Monophosphate-Activated Protein Kinase-ɑ – Proliferator-Activated Receptor-r Coactivator-1ɑ Signaling in Skeletal Muscle of Mice With Heart Failure 2020 ·Circulation Heart Failure ·Junichi Matsumoto, Shingo Takada, Takaaki Furihata, Hideo Nambu, Naoya Kakutani, Satoshi Maekawa, Wataru Mizushima, (unknown), Arata Fukushima, Takashi Yokota, Shinya Tanaka, Haruka Handa, Hisataka Sabe, Shintaro Kinugawa	28
7	Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure 2019 ·European Journal of Pharmacology ·Hideo Nambu, Shingo Takada, Arata Fukushima, Junichi Matsumoto, Naoya Kakutani, Satoshi Maekawa, (unknown), (unknown), Takaaki Furihata, Takashi Katayama, (unknown), (unknown), (unknown), Takashi Yokota, Shintaro Kinugawa	50
8	Linoleic acid improves assembly of the CII subunit and CIII2/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure 2019 ·Cell Communication and Signaling ·Satoshi Maekawa, Shingo Takada, Hideo Nambu, Takaaki Furihata, Naoya Kakutani, Daiki Setoyama, (unknown), Dongchon Kang, Hisataka Sabe, Shintaro Kinugawa	36
9	Mitochondrial reactive oxygen species generation in blood cells is associated with disease severity and exercise intolerance in heart failure patients 2019 ·Scientific Reports ·(unknown), Takashi Yokota, Takayuki Nakajima, Shingo Takada, (unknown), Takaaki Furihata, Satoshi Maekawa, Hideo Nambu, Takashi Katayama, Arata Fukushima, (unknown), Naoki Ishimori, Flemming Dela, Shintaro Kinugawa, Toshihisa Anzai	41
10	Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure 2018 ·Journal of Cachexia Sarcopenia and Muscle ·Masaya Tsuda, Arata Fukushima, Junichi Matsumoto, Shingo Takada, Naoya Kakutani, Hideo Nambu, (unknown), Takaaki Furihata, Takashi Yokota, Koichi Okita, Shintaro Kinugawa, Toshihisa Anzai	42
11	Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure 2018 ·Circulation Journal ·Naoya Kakutani, Arata Fukushima, Takashi Yokota, Takashi Katayama, Hideo Nambu, (unknown), Satoshi Maekawa, Takahiro Abe, Shingo Takada, Takaaki Furihata, Kota Ono, Koichi Okita, Shintaro Kinugawa, Toshihisa Anzai	11
12	18F-FDG PET findings of pericardial lymphangiohemangioma 2016 ·Journal of Nuclear Cardiology ·Tadao Aikawa, Masanao Naya, Noriko Oyama‐Manabe, Satoshi Maekawa, Hideo Nambu, Hirofumi Mitsuyama, Kenji Hirata, (unknown), Hiroyuki Tsutsui	0
13	MORPHOLOGY OF A HYNOBIUS SP. WITH TRANSPARENT AND SPINDLE TYPE EGG SAC FROM THE CENTRAL JAPAN : Taxonomy and Systematics : 1990 ·ZOOLOGICAL SCIENCE ·Hideo Nambu	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact